menu
    • menu

    Company profile for Hookipa Pharma

    NEW Drugs in Dev: 10
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    LEBSA- Your strategic API source for niche molecules.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    HOOKIPA Pharma Inc. is a clinical-stage biopharmaceutical company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on a proprietary arenavirus platform that is designed to reprogram the body’s immune system. We are using our ‘‘off-the-shelf’’ technologies, VaxWave®* and TheraT®*, to elicit directly within patients a powerful and durable response of antigen-specific killer...
    HOOKIPA Pharma Inc. is a clinical-stage biopharmaceutical company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on a proprietary arenavirus platform that is designed to reprogram the body’s immune system. We are using our ‘‘off-the-shelf’’ technologies, VaxWave®* and TheraT®*, to elicit directly within patients a powerful and durable response of antigen-specific killer T cells and antibodies, thereby activating essential immune defences against infectious diseases and cancers.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Hookipa PharmaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    350 Fifth Avenue, Room/Suite 7240 New York, NY 10118
    Telephone
    Telephone
    +43 1 890 63 60
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.hookipapharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    HOOKIPA Pharma Completes Sale Of HBV & HIV Assets To Gilead
    HOOKIPA Pharma Completes Sale Of HBV & HIV Assets To Gilead

    31 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/31/3178274/0/en/HOOKIPA-Pharma-Announces-Completion-of-Sale-of-HBV-and-HIV-Assets-to-Gilead.html

    GLOBENEWSWIRE
    31 Oct 2025
    Share Share
    Hookipa, Having Sold Off Vaccines to Gilead, Opts to Wind Down
    Hookipa, Having Sold Off Vaccines to Gilead, Opts to Wind Down

    21 Jul 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/hookipa-having-sold-vaccines-gilead-opts-wind-down

    FIERCE BIOTECH
    21 Jul 2025
    Share Share
    HOOKIPA Pharma to Voluntarily Delist and Deregister Common Stock
    HOOKIPA Pharma to Voluntarily Delist and Deregister Common Stock

    18 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/18/3118174/0/en/HOOKIPA-Pharma-Announces-Intention-to-Voluntarily-Delist-and-Deregister-its-Common-Stock.html

    GLOBENEWSWIRE
    18 Jul 2025
    Share Share
    Gilead pays partner Hookipa $10M for HBV, HIV vaccines
    Gilead pays partner Hookipa $10M for HBV, HIV vaccines

    23 May 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/gilead-pays-partner-hookipa-10m-take-over-hbv-hiv-vaccine-programs

    FIERCE BIOTECH
    23 May 2025
    Share Share
    HOOKIPA Issues Statement On Potential Poolbeg Pharma Deal
    HOOKIPA Issues Statement On Potential Poolbeg Pharma Deal

    20 Feb 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/02/20/3030028/0/en/HOOKIPA-Pharma-Inc-HOOKIPA-Statement-regarding-potential-combination-for-Poolbeg-Pharma-plc-Poolbeg.html

    GLOBENEWSWIRE
    20 Feb 2025
    Share Share
    HOOKIPA Completes Enrollment For Phase 1b HB-500 HIV Trial
    HOOKIPA Completes Enrollment For Phase 1b HB-500 HIV Trial

    30 Jan 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/01/30/3017871/0/en/HOOKIPA-Pharma-Announces-Enrollment-Completion-of-Phase-1b-Clinical-Trial-Evaluating-HB-500-for-the-Treatment-of-HIV.html

    GLOBENEWSWIRE
    30 Jan 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search